2nd i-osi congress 2020day 2 - saturday, 21st march 2020 2nd i-osi congress 2020 timing topic 08:00...

2nd I-OSI CONGRESS 2020

20-21MARCH, 2020

TATA MEDICAL CENTERKOLKATA

SCIENTIFIC PROGRAM

2ND I-OSICONGRESS 2020

Timing Topic

14:40 - 15:15 Case Colloquium: Speaker: TBA

15:15 - 16:15 Session 4: Adverse Event Management in Immunotherapy of Cancer

15:15 - 15:35 Keynote Talk: Managing Immune-related Adverse Events Speaker: Dr. Sanjeev Agarwala Professor, Temple University School of Medicine, Washington

15:35 - 16:15 Case Colloquium on Adverse Event Management Speaker: TBA

16:15 - 16:30 Tea Break

16:30 - 18:15 Session 5: Head & Neck

16:30 - 16:55 Keynote Talk: Check-point Inhibitor Therapy in Head & Neck Cancers, TMH Experience Speaker: Dr. Vijay Patil

16:55 - 17:30 Debate: Immunotherapy should be First Line for Head & Neck Cancers Moderator: Dr. Hemant Malhotra For the Motion: Dr. Abhishek Anand Against the Motion: Dr. Senthil Rajappa

17:30 - 18:15 Case Colloquium: Immunotherapy in Head & Neck Cancers Speaker: TBA

18:15 - 19:30 Session 6: Introduction to topic

18:15 - 19:00 Keynote Address: The Next Generation of Cellular Immunotherapies Speaker: Dr. Boro Dropulic Chief Scientific Officer, Lentigen Technology Inc.

19:00 - 19:30 Jugalbandi of Chemotherapists Speakers: Dr. Advani, Dr. Chandy, Dr. Raghunada Rao, Dr. Mohandas Moderator: Dr. Tapan Saikia

19:30 Onwards General Body Meeting

20:00 Onwards Dinner

Timing Topic

09:00 - 10:30 Executive committee meeting

10:30 - 11:30 Session 1: Introduction, and Selected and Invited Papers

10:30 - 10:50 CMCH Vellore: NK Cell Therapy Speaker: Prof. Vikram Mathews

10:50 - 11:10 TMH Mumbai: Multi-center Checkpoint Blockade Therapy Database Speaker: Prof. Jyoti Bajpai

11:10 - 11:30 TMC Kolkata: GIFT Study-Oral Cancers Speaker: Prof. Geetashree Mukherjee

11:30 - 13:30 Session 2: Translational Topics

Introduction Speaker: Dr. Moni Kuriokose

11:30 - 11:50 SIGNAL Program: A Human Immunomonitoring Platform for Predicting Right Treatment to Right Patients Speaker: Dr. Laurent Renia

11:50 - 12:10 T-Cell Cellular Therapy Model in Solid Organ Cancer Speaker: Dr. Girdhari Lal

12:10 - 12:30 Pre-Clinical Data on Indigenous CAR T-Cell Speaker: Dr. Rahul Purwar

12:30 - 12:50 Imaging based Immuno-profiling of Onco-Immunology Speaker: Dr. Akhila

12:50 - 13:10 Adjuvants to Checkpoint Blockade Speaker: Dr. Amit Awasthi

13:10 - 13:30 Dissecting the Mechanism of Response and Resistance to Immune-checkpoint Therapy in NKT Lymphoma Speaker: Dr. Olaf Roeschke

13:30 - 14: 15 Lunch

14:15 - 15:15 Session 3: GI & HPB

14:15 - 14:40 Keynote: “Diverse players regulate tumor immune interactions in GI versus other Cancers” Speaker: Dr. Subhra Biswas Principal Investigator, Singapore Immunology Network (SIgN)

Day 1 - Friday, 20th March 2020

Day 1 - Friday, 20th March 2020

Timing Topic

14:40 - 15:15 Case Colloquium: Speaker: TBA

15:15 - 16:15 Session 4: Adverse Event Management in Immunotherapy of Cancer

15:15 - 15:35 Keynote Talk: Managing Immune-related Adverse Events Speaker: Dr. Sanjeev Agarwala Professor, Temple University School of Medicine, Washington

15:35 - 16:15 Case Colloquium on Adverse Event Management Speaker: TBA

16:15 - 16:30 Tea Break

16:30 - 18:15 Session 5: Head & Neck

16:30 - 16:55 Keynote Talk: Check-point Inhibitor Therapy in Head & Neck Cancers, TMH Experience Speaker: Dr. Vijay Patil

16:55 - 17:30 Debate: Immunotherapy should be First Line for Head & Neck Cancers Moderator: Dr. Hemant Malhotra For the Motion: Dr. Abhishek Anand Against the Motion: Dr. Senthil Rajappa

17:30 - 18:15 Case Colloquium: Immunotherapy in Head & Neck Cancers Speaker: TBA

18:15 - 19:30 Session 6: Introduction to topic

18:15 - 19:00 Keynote Address: The Next Generation of Cellular Immunotherapies Speaker: Dr. Boro Dropulic Chief Scientific Officer, Lentigen Technology Inc.

19:00 - 19:30 Jugalbandi of Chemotherapists Speakers: Dr. Advani, Dr. Chandy, Dr. Raghunada Rao, Dr. Mohandas Moderator: Dr. Tapan Saikia

19:30 Onwards General Body Meeting

20:00 Onwards Dinner

Timing Topic

09:00 - 10:30 Executive committee meeting

10:30 - 11:30 Session 1: Introduction, and Selected and Invited Papers

10:30 - 10:50 CMCH Vellore: NK Cell Therapy Speaker: Prof. Vikram Mathews

10:50 - 11:10 TMH Mumbai: Multi-center Checkpoint Blockade Therapy Database Speaker: Prof. Jyoti Bajpai

11:10 - 11:30 TMC Kolkata: GIFT Study-Oral Cancers Speaker: Prof. Geetashree Mukherjee

11:30 - 13:30 Session 2: Translational Topics

Introduction Speaker: Dr. Moni Kuriokose

11:30 - 11:50 SIGNAL Program: A Human Immunomonitoring Platform for Predicting Right Treatment to Right Patients Speaker: Dr. Laurent Renia

11:50 - 12:10 T-Cell Cellular Therapy Model in Solid Organ Cancer Speaker: Dr. Girdhari Lal

12:10 - 12:30 Pre-Clinical Data on Indigenous CAR T-Cell Speaker: Dr. Rahul Purwar

12:30 - 12:50 Imaging based Immuno-profiling of Onco-Immunology Speaker: Dr. Akhila

12:50 - 13:10 Adjuvants to Checkpoint Blockade Speaker: Dr. Amit Awasthi

13:10 - 13:30 Dissecting the Mechanism of Response and Resistance to Immune-checkpoint Therapy in NKT Lymphoma Speaker: Dr. Olaf Roeschke

13:30 - 14: 15 Lunch

14:15 - 15:15 Session 3: GI & HPB

14:15 - 14:40 Keynote: “Diverse players regulate tumor immune interactions in GI versus other Cancers” Speaker: Dr. Subhra Biswas Principal Investigator, Singapore Immunology Network (SIgN)


Day 2 - Saturday, 21st March 2020


Timing Topic

08:00 - 09:30 Session 7: Paediatric & Young Adult Cancers

08:00 - 08:20 Keynote Talk Speaker: Dr. Gaurav Narula

08:20 - 09:30 Case Colloquium Speaker: TBA

09:30 - 10:30 Session 8: Tough Calls in Immuno-oncology Practice

09:30 - 09:50 Keynote Talk: Immunotherapy in Challenging Situations Speaker: Dr. Sanjeev Agarwala Professor, Temple University School of Medicine, Washington

09:50 - 10:30 Case Colloquium Speakers: Dr. Jyoti Bajpai, Dr. Jair Bar, Dr. Sanjeev Agarwala

10:30 - 10:45 Tea-Break

10.45 - 11:45 Session 9: Inauguration & Plenary Session

10:45 - 10:50 Introduction Speaker: Prof. Shubada Chiplunkar

10:50 - 11:45 Cellular Therapy of Infections in the Cancer Patients Speaker: Prof. David Gotlieb Program Director of the Blood and Marrow Transplant Unit at Westmead Hospital Professor, University of Sydney

11:45 - 12:45 Session 10: Genito-urinary Cancer

11:45 - 12:15 Case Colloquium I: Metastatic Renal Cell Cancer Speaker: Dr. Amit Rauthan

12:15 - 12:45 Case Colloquium II: Metastatic Cancer Urinary Bladder Speaker: Dr. Vineet Talwar

12:45 - 13:30 Lunch

13:30 - 15:45 Session 11: Haematological Cancers

13:30 - 13:55 Keynote: Current CAR T-Cell Therapy Updates from Clinical Trial Experience Speaker: Prof. David Gottlieb Program Director of the Blood and Marrow Transplant Unit at Westmead Hospital Professor, University of Sydney

Timing Topic

13:55 - 14:30 Debate: Check Point Therapy in Haemetological Malignancy, has the Time Arrived for Standard of Care? Moderator: Prof. Atul Sharma For the Motion: Dr. Anu Korula Against the Motion: Dr. Prashant Ganesan

14:30 - 14:55 Talk: Immunotherapy of Myelomas Evidence Based Review Speaker: Dr. Hari Menon

14:55 - 15:45 Case Colloquium Speaker: Dr. Jeevan Kumar

15:45 - 16.00 Tea-Break

16:00 - 17:30 Session 12: Lung Cancer

16:00 - 16:25 Keynote: Beyond PD-1 & PDL-1 Immunotherapy in Lung Cancer Speaker: Dr. Jair Bar Deputy Director, Institute of Oncology, Sheba Medical Center, and Weizmann Institute of Science. Israel


17:30 Onwards Closing Ceremony, Prize Distribution and Vote of Thanks

Day 2 - Saturday, 21st March 2020

Timing Topic

08:00 - 09:30 Session 7: Paediatric & Young Adult Cancers

08:00 - 08:20 Keynote Talk Speaker: Dr. Gaurav Narula


09:30 - 10:30 Session 8: Tough Calls in Immuno-oncology Practice

09:30 - 09:50 Keynote Talk: Immunotherapy in Challenging Situations Speaker: Dr. Sanjeev Agarwala Professor, Temple University School of Medicine, Washington

09:50 - 10:30 Case Colloquium Speakers: Dr. Jyoti Bajpai, Dr. Jair Bar, Dr. Sanjeev Agarwala

10:30 - 10:45 Tea-Break

10.45 - 11:45 Session 9: Inauguration & Plenary Session

10:45 - 10:50 Introduction Speaker: Prof. Shubada Chiplunkar

10:50 - 11:45 Cellular Therapy of Infections in the Cancer Patients Speaker: Prof. David Gotlieb Program Director of the Blood and Marrow Transplant Unit at Westmead Hospital Professor, University of Sydney

11:45 - 12:45 Session 10: Genito-urinary Cancer

11:45 - 12:15 Case Colloquium I: Metastatic Renal Cell Cancer Speaker: Dr. Amit Rauthan

12:15 - 12:45 Case Colloquium II: Metastatic Cancer Urinary Bladder Speaker: Dr. Vineet Talwar

12:45 - 13:30 Lunch

13:30 - 15:45 Session 11: Haematological Cancers

13:30 - 13:55 Keynote: Current CAR T-Cell Therapy Updates from Clinical Trial Experience Speaker: Prof. David Gottlieb Program Director of the Blood and Marrow Transplant Unit at Westmead Hospital Professor, University of Sydney

21 MARCH, 2020 | DAY 2

Timing Topic

13:55 - 14:30 Debate: Check Point Therapy in Haemetological Malignancy, has the Time Arrived for Standard of Care? Moderator: Prof. Atul Sharma For the Motion: Dr. Anu Korula Against the Motion: Dr. Prashant Ganesan

14:30 - 14:55 Talk: Immunotherapy of Myelomas Evidence Based Review Speaker: Dr. Hari Menon

14:55 - 15:45 Case Colloquium Speaker: Dr. Jeevan Kumar

15:45 - 16.00 Tea-Break

16:00 - 17:30 Session 12: Lung Cancer

16:00 - 16:25 Keynote: Beyond PD-1 & PDL-1 Immunotherapy in Lung Cancer Speaker: Dr. Jair Bar Deputy Director, Institute of Oncology, Sheba Medical Center, and Weizmann Institute of Science. Israel


17:30 Onwards Closing Ceremony, Prize Distribution and Vote of Thanks


2nd i-osi congress 2020day 2 - saturday, 21st march 2020 2nd i-osi congress 2020 timing topic 08:00...

Documents